1. Home
  2. BATRA vs TARS Comparison

BATRA vs TARS Comparison

Compare BATRA & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

HOLD

Current Price

$47.25

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$67.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRA
TARS
Founded
1991
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BATRA
TARS
Price
$47.25
$67.76
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$57.00
$89.00
AVG Volume (30 Days)
48.9K
562.0K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$12.40
$56.26
Revenue Next Year
$8.54
$26.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
146.71
52 Week Low
$38.67
$38.51
52 Week High
$50.45
$85.25

Technical Indicators

Market Signals
Indicator
BATRA
TARS
Relative Strength Index (RSI) 53.94 42.63
Support Level $45.81 $65.62
Resistance Level $48.05 $78.34
Average True Range (ATR) 1.32 3.13
MACD -0.27 -0.55
Stochastic Oscillator 34.79 3.58

Price Performance

Historical Comparison
BATRA
TARS

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: